You cannot register for this webinar

Ensuring the timely delivery of effective viral vaccines is crucial in combatting infectious diseases. However, traditional manufacturing methods pose challenges, such as complexity, length of process development, and limited scalability for rapid commercialization. Integrated and automated manufacturing technologies offer cost-effective, scalable, and highly productive processes. These technologies are designed to accommodate various expression systems, vaccine applications, and capacity requirements, streamlining vaccine development. Structured fixed-bed bioreactors are key to these advancements, enabling high cell densities and superior specific cell productivities. Their ability to ensure homogeneous cell distribution and media flow leads to reproducible outcomes across scales, simplifying the scale-up process. This intensification significantly reduces complexity, footprint, and capital expenditure, ultimately lowering the cost per dose. This presentation will focus on technology innovations utilizing fixed-bed technology innovations to deliver capacity with a low footprint, process flexibility, and accelerated development and scale-up timelines.